OMER
Omeros Corp
NASDAQ · Pharmaceuticals
$11.23
+0.49 (+4.56%)
Open$11.00
Previous Close$10.74
Day High$11.41
Day Low$10.89
52W High$17.65
52W Low$2.95
Volume—
Avg Volume1.34M
Market Cap796.21M
P/E Ratio—
EPS$-2.02
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+480.3% upside
Current
$11.23
$11.23
Target
$65.17
$65.17
$47.12
$65.17 avg
$100.64
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 179.53M | 176.40M | 195.82M |
| Net Income | 39.25M | 28.13M | 36.61M |
| Profit Margin | 21.9% | 16.0% | 18.7% |
| EBITDA | 43.74M | 50.64M | 56.07M |
| Free Cash Flow | 39.04M | 39.72M | 27.68M |
| Rev Growth | -2.9% | +12.2% | +10.8% |
| Debt/Equity | 0.71 | 0.72 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |